Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development

Published:2022-07-02 Issue:9 Volume:15 Page:2057-2074
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Kast Johannes¹^ORCID,Nozohouri Saeideh²,Zhou Di¹,Yago Marc R.¹^ORCID,Chen Po‐Wei³,Ahamadi Malidi³,Dutta Sandeep³,Upreti Vijay V.¹^ORCID

Affiliation:

1. Clinical Pharmacology Modeling & Simulation, Amgen Inc. South San Francisco California USA

2. Department of Pharmaceutical Sciences School of Pharmacy, Texas Tech University Health Sciences Center Amarillo Texas USA

3. Clinical Pharmacology Modeling & Simulation, Amgen Inc. Thousand Oaks California USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13349

Reference120 articles.

1. Mechanisms of granule-dependent killing

2. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules

3. CAR T cells: continuation in a revolution of immunotherapy

4. Teaching an old dog new tricks: next-generation CAR T cells

5. Engineered T Cell Therapy for Cancer in the Clinic

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian network analysis of risk classification strategies in the regulation of cellular products;Artificial Intelligence in Medicine;2024-09

2. Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers;Clinical Pharmacology & Therapeutics;2024-08-16

3. Moving the needle for oncology dose optimization: A call for action;Clinical and Translational Science;2024-06

4. Moving the needle for oncology dose optimization: A call for action;CPT: Pharmacometrics & Systems Pharmacology;2024-05-22

5. Moving the Needle for Oncology Dose Optimization: A Call for Action;Clinical Pharmacology & Therapeutics;2024-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3